Basic physiology of salt and water handling
The kidneys handle sodium and water separately. Sodium handling is influenced by sympathetic tone, aldosterone (amongst other stimuli) and diuretics acting on three major sites of sodium reabsorption. Sodium reabsorption takes place without reabsorption of water because the renal tubule is impermeable to water unless aquaporin-2 water channels are inserted into the luminal surface of the collecting duct tubules, allowing water to be reabsorbed in the medulla 5 . Vasopressin acts on V2 receptors to cause insertion of the aquaporin channels. The major stimuli to vasopressin release are: a rise in plasma osmolality effective or true hypovolaemia non-osmotic stimuli, including pain and nausea.
Hyponatraemia
Common causes of hyponatraemia are summarised in Table 1 . The reference range for plasma sodium is 134-144 mmol/l. Sick patients commonly have hyponatraemia due to loss of intracellular osmolytes drawing water into the extracellular fluid. In the insulinopenic state, hyperglycaemia lowers serum sodium by 1.5 mmol/l for every 3.5 mmol/l increase in plasma glucose by translocating intracellular water 6 . This may be counterbalanced by glycosuria causing a water diuresis, and conversely lead to severe hypernatraemia as in hyperosmolar non-ketotic coma.
Significant hyponatraemia, with a rapid fall to below 120 mmol/l, causes generalised encephalopathy leading to stupor, coma and death 3 . It arises from excess water and/or sodium loss and is sustained by an inability to elaborate dilute urine due to stimulation of AVP release by non-osmotic mechanisms.
Diagnostic evaluation
Clinical evaluation is directed towards an assessment of extracellular volume (Table 2 ) and the presence of thyroid, pituitary, adrenal, cardiac, hepatic or renal disease 7 . Peripheral oedema in cardiac failure and ascites in hepatic cirrhosis indicate sodium retention, but the effective circulating volume is reduced, stimulating AVP production 8, 9 .
Thiazide diuretics frequently cause hyponatraemia 2, 10 , particularly in elderly women who may respond by increased thirst and weight gain, with a fall in sodium to below 125 mmol/l within a few days. In an analogous way to beer drinkers' potomania, a high intake of sodium-free fluid and poor nutrition restrict urine output due to reduced osmolar load 11 .
Syndrome of inappropriate antidiuresis
Diagnosis of the syndrome of inappropriate antidiuresis requires the presence of hypo-osmolar hyponatraemia with urine sodium above 40 mmol/l, a urine/plasma osmolality ratio above 1, and normal pituitary, adrenal and thyroid function 12 . Elevated AVP persists in the face of low plasma osmolality due to ectopic release from tumours, non-osmotic stimuli such as pain, and many drugs (Table 3) . Hyponatraemia after surgery follows infusion of hypotonic fluids, with oliguria produced by AVP release due to anaesthetics, pain, nausea and opiates. Hyponatraemia with cerebral oedema may develop rapidly, particularly in children 13 and menstruating females 14 , possibly due to inhibition of brain volume regulation by oestrogen 15 .
Treatment of hyponatraemia
During the first 48 hours of exposure to hyponatraemia, cell swelling is successfully counterbalanced by loss of intracellular potassium and organic osmolytes 16 . Reversal is a much slower process. In symptomatic hyponatraemia of more than 48 hours' duration rapid correction risks causing cell shrinkage and osmotic demyelination, with signs of central pontine myelinosis manifesting two days later. Hypertonic or isotonic saline should be used to correct hyponatraemia at a rate less than 0.5 mmol/l/h and not exceeding 10-12 mmol/l per 24 hours until symptoms subside 16, 17 . Hyponatraemia of acute onset requires rapid correction until symptoms heralding cerebral oedema disappear. Asymptomatic patients can be restricted to a litre of fluid a day.
In the future, measurement of urinary aquaporin-2 excretion reflecting the renal response to vasopressin may prove helpful in defining causes of hyponatraemia, and specific oral V2 receptor antagonists may be useful in management 9 .
Hypernatraemia
Hypernatraemia (Table 4) is common in hospital patients, arising from water loss with inadequate replacement. Poor prognosis is related more to rapid correction than to the degree of hypernatraemia 4 .
Relative water deficiency is sustained, despite thirst, by lack of access to water in the young, the old and the infirm. Ability to concentrate urine may be reduced by osmotic diuresis (intravenous nutritional supplements, hyperglycaemia or other osmotic diuretics), loop diuretics, resolution of obstructive nephropathy or failure of arginine vasopressin (AVP) action. It is generally reduced in the elderly.
Hypernatraemia has been described following intrauterine saline for attempted abortion and oral ingestion in non-accidental salt poisoning in children 18 .
Treatment of hypernatraemia
Treatment of hypernatraemia follows similar principles to that of hyponatraemia, reducing serum sodium concentration at a maximal rate of 0.5 mmol/l/h and not more than 10 mmol/l per 24 hours with 0.45% sodium chloride (half normal saline) or 5% dextrose, and avoiding cerebral oedema. A helpful quantitative approach is contained in the article by Adrogue and Madias 19 .
Diabetes insipidus
Cranial diabetes insipidus (DI) is due to lack of AVP, which may be partial, and 50% of cases are idiopathic. Nephrogenic DI follows damage to the renal concentrating mechanism by drugs (eg lithium, amphotericin B, foscarnet), hypercalcaemia, nephrocalcinosis and Fanconi 
Potassium disorders
The glomerular filtration rate (GFR), urinary flow rate and renal tubular exchanges regulate renal potassium excretion.
Hypokalaemia
The reference range for plasma potassium is 3.5-5.0 mmol/l. Serum levels are about 0.5 mmol/l higher due to release of platelet potassium during clotting 20 . Hypokalaemia (Table 5) arises with transcellular shifts, extrarenal (gastrointestinal) or renal loss. Alkalosis moves potassium into cells, leading to the development of kaliuria by inhibition of proximal resorption of bicarbonate, promoting potassium exchange in the distal tubule and increased distal tubular flow. In normotensive young patients with unexplained hypokalaemia and raised bicarbonate, diuretic abuse, surreptitious vomiting and inherited tubulopathy should be considered 21 . Diuretic abuse is usually denied and must be screened for, but characteristically urinary chloride falls rapidly to low levels when the patient stops diuretics to attend the clinic. Urinary chloride will also be low in surreptitious vomiting and laxative abuse. The latter, also denied and requiring screening for, usually causes hypokalaemic acidosis and must be distinguished from renal tubular acidosis.
Bartter's syndrome is caused by one of several mutations deactivating sodium and chloride reabsorption at precisely the same site of action as frusemide 22 , whereas in Gitelman's syndrome the mutations affect the same site of action as thiazide diuretics 23 . Bartter's is rarely seen in adults, and predictably Gitelman's is associated with hypocalciuria. Hypertensive hypokalaemia with renal potassium wasting suggests mineralocorticoid excess 24 .
Diagnostic evaluation
A careful drug and family history is essential. Raised plasma bicarbonate is a useful confirmatory test. Renal loss is suggested by urinary potassium above 15 mmol/l or above 25 mol/day provided that the patient is sodium replete. In hypertensive patients the aldosterone/ renin ratio is a useful screening test for Conn's syndrome 25 and glucocorticoid remediable hyperaldosteronism. Low levels of both aldosterone and renin suggest Cushing's syndrome or pseudohyperaldosteronism, for example lack of 11-beta hydroxysteroid dehydrogenase activity, liquorice abuse 26 and Liddle's syndrome (an activating mutation of the amiloride sensitive epithelial sodium channel 22 ).
Hyperkalaemia
Hyperkalaemia (Table 6 ) may be caused by transcellular shifts, reduced GFR or tubular dysfunction exacerbated by high potassium intake. Shifts occur in hyperchloraemic acidosis and some poisonings, but not in ketoacidosis or lactic acidosis where the anions readily enter cells.
Hyperkalaemia presents more frequently with aggressive treatment of heart failure combining angiotensinconverting enzyme inhibitors, angiotensin II antagonists, aldosterone antagonists 27 and beta-blockers. Drugs and other hyperkalaemic factors interact to cause serious hyperkalaemia, for example, potassium-sparing diuretics and non-steroidal anti-inflammatory drugs with salt substitutes and apple or other fruit juices which contain potassium. The elderly and diabetics are particularly vulnerable to superadded intercurrent illness reducing renal perfusion 28 results from an inherited renal tubule epithelial sodium channel defect (pseudohypoaldosteronism) or may follow obstructive nephropathy.
